Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab

Keyphrases

• Pembrolizumab 100%
• Thrombotic Thrombocytopenic Purpura 100%
• ADAMTS13 75%
• Thrombocytopenia 50%
• Thrombotic Microangiopathy 50%
• Right-sided 25%
• Activity Level 25%
• Renal Function 25%
• Oncology 25%
• Life-threatening 25%
• Hemoglobin 25%
• Emergency Department 25%
• Serum Creatinine 25%
• Young Males 25%
• Platelet Count 25%
• Treatment Complications 25%
• Leukocytosis 25%
• Acute Onset 25%
• Blood Urea Nitrogen 25%
• Normal Saline 25%
• Shortness of Breath 25%
• Packed Red Blood Cells 25%
• Management Outcome 25%
• Further Treatment 25%
• Hyponatremia 25%
• Numbness 25%
• Appetite Loss 25%
• Saline Bolus 25%
• Generalized Weakness 25%
• Slurred Speech 25%
• Schistocytes 25%
• Metastatic Urothelial Carcinoma 25%
• ADAMTS13 Protein 25%
• Imaging Workup 25%
• Laboratory Changes 25%
• PLASMIC Score 25%
• Comorbitidy 25%

Medicine and Dentistry

• Thrombotic Thrombocytopenic Purpura 100%
• Pembrolizumab 100%
• Von Willebrand Factor Cleaving Proteinase 50%
• Thrombocytopenia 33%
• Oncology 16%
• Platelet 16%
• Arm 16%
• Emergency Department 16%
• Kidney Function 16%
• Transitional Cell Carcinoma 16%
• Creatinine 16%
• Dyspnea 16%
• Leukocytosis 16%
• Paresthesia 16%
• Weakness 16%
• Hyponatremia 16%
• Loss of Appetite 16%
• Schistocyte 16%
• Slurred Speech 16%
• Immunotherapy 16%
• Blood Urea Nitrogen 16%
• Table Salt 16%
• Erythrocyte 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Pembrolizumab 100%
• Thrombotic Thrombocytopenic Purpura 100%
• Von Willebrand Factor Cleaving Proteinase 50%
• Thrombocytopenia 33%
• Creatinine 16%
• Weakness 16%
• Loss of Appetite 16%
• Dyspnea 16%
• Immunotherapy 16%
• Paresthesia 16%
• Ureaplasma 16%
• Leukocytosis 16%
• Hyponatremia 16%
• Transitional Cell Carcinoma 16%
• Table Salt 16%
• Slurred Speech 16%